文献速递头颈外科

营养风险指数与头颈癌同步放化疗患者结局的关联

Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy.
PubMed 文献 · Head Neck · 2020-06-20

结果显示治疗前后NRI平均从110降至99(P<.01),治疗前NRI风险分级与总生存及复合治疗并发症风险相关。

要点

  • 头颈癌同步放化疗患者治疗前后NRI显著下降。
  • 治疗前NRI风险分级可能预测总生存。
  • 治疗前NRI风险分级与复合治疗并发症风险相关。

核心结论

  • 头颈癌同步放化疗患者治疗前后NRI显著下降,治疗前NRI风险分级可能预测总生存和复合治疗并发症。

主要发现

  • 治疗前和治疗后平均NRI分别为110(SD 3)和99(SD 12),差异有统计学意义(P < .01)。
  • 多因素分析显示治疗前NRI风险分级、年龄、ECOG状态和肿瘤亚部位与总生存相关。
  • 治疗前NRI风险分级与治疗相关并发症风险相关。

临床怎么用

  • 治疗前NRI风险分级或可用于识别同步放化疗头颈癌患者中总生存较差和并发症风险较高者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients receiving chemoradiotherapy for head and neck cancer (HNC) are often malnourished. We assessed the utility of nutritional risk index (NRI) in HNC patients undergoing chemoradiotherapy. METHODS: A population-based retrospective review of HNC patients treated with curative chemoradiation was performed. Demographics, anthropometrics, overall survival (OS), and the composite treatment complication rate (G-tube dependence, radiation incompletion, 90-day mortality, and unplanned hospitalization) were collected. RESULTS: Two hundred ninety-two patients were identified. Average pretreatment and posttreatment NRI were 110 (SD 3) and 99 (SD 12), respectively (P < .01). Pretreatment NRI risk category, age, ECOG status, and tumor subsites were associated with OS on multivariate analysis. Pretreatment NRI risk category was associated with risk of treatment related complications. CONCLUSIONS: There was a significant decrease between pretreatment and posttreatment NRI in HNC patients receiving chemoradiation. Pretreatment NRI risk category may predict OS and composite treatment complications. Investigation of NRI as a prognostic factor is warranted.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Oh J, Liu A, Tran E, et al. Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy. Head Neck. 2020. PMID: 32562319. doi:10.1002/hed.26315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。